Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.60
Bid: 76.90
Ask: 78.40
Change: -0.60 (-0.78%)
Spread: 1.50 (1.951%)
Open: 76.60
High: 76.60
Low: 76.60
Prev. Close: 77.20
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Comment on Budget Statement

9 Jul 2015 14:16

RNS Number : 6481S
GCP Infrastructure Investments Ltd
09 July 2015
 



 

 

9 July 2015

 

GCP Infrastructure Investments Limited

("the Company")

Comment on Budget Statement

 

The Board of Directors of the Company has noted the Chancellor's statements in yesterday's Budget relating to the removal of the Climate Change Levy exemption for certain renewable energy projects from 1 August 2015.

Gravis Capital Partners LLP, the investment adviser to the Company, has conducted a preliminary review of the potential impact of these statements on the assets of the Company. It is the view of the Board, as advised by the investment adviser, that a minority (by value) of the projects against which the Company has provided debt will see a modest reduction in the forecast net cashflows available to service such debt during the period to 2022.

However, it is the opinion of the investment adviser that these reductions will not have a material impact on the ability of the projects to service such debt. As a result, it is the view of the Board, as advised by the investment adviser, that the cashflows expected to arise from the investments held by the Company will be wholly unaffected by the removal of the Climate Change Levy exemption.

Ian Reeves, the chairman of the Company, commented "The Company offers shareholders exposure to subordinated PFI debt and related assets including renewable energy. Its focus on investing in debt instruments ensures that the Company benefits from an element of protection whereby equity holders in investee projects suffer the first loss arising from any reduction in projects' free cash flows. In light of yesterday's announcement of a reduction in the level of public sector support for certain renewable energy projects, it is pleasing to see that the fundamentally conservative approach of the Company in providing debt to such projects leaves the Company essentially unaffected by that announcement".

 

Contact details:

 

Gravis Capital Partners LLP

 

Stephen Ellis

+44 (0)20 7518 1495

Rollo Wright

+44 (0)20 7518 1493

 Stifel Nicolaus Europe Limited

 

Neil Winward

+44 (0)20 7710 7600

Mark Bloomfield

 

Tunga Chigovanyika

 

Cenkos Securities

 

Dion Di Miceli

+44 (0)20 7397 1921

Tom Scrivens

+44 (0)20 7397 1915

Buchanan

 

Charles Ryland

+44 (0)20 7466 5000

Victoria Watkins

 

 

Notes to Editors

The Company

The Company is a closed-ended London Stock Exchange-listed investment company that seeks to generate returns from senior and subordinated infrastructure debt and related and/or similar assets. The Company is advised by Gravis Capital Partners LLP.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLVDEIAIIE
Date   Source Headline
20th Apr 20207:00 amRNSNet Asset Value(s)
31st Mar 20207:00 amRNSTotal Voting Rights
20th Mar 20207:00 amRNSCovid-19 update
10th Mar 20204:53 pmRNSDirector/PDMR Shareholding
9th Mar 20209:23 amRNSAdditional Listing and Total Voting Rights
28th Feb 20207:00 amRNSAdditional Listing
13th Feb 20201:23 pmRNSResult of AGM and EGM
13th Feb 20201:00 pmRNSDirectorate Change
13th Feb 20207:00 amRNSScrip Share Reference Price
3rd Feb 20207:00 amRNSInvestor Report as at 31 December 2019
30th Jan 202010:52 amRNSInitiation research from QuotedData
24th Jan 202010:22 amRNSDividend Declaration & Scrip Dividend Alternative
15th Jan 20207:00 amRNSNet Asset Value(s)
3rd Jan 20207:00 amRNSNotice of AGM and EGM Circulars
12th Dec 201910:45 amRNSReplace - Annual report and financial statements
12th Dec 20197:00 amRNSAnnual report and financial statements
29th Nov 20197:00 amRNSTotal Voting Rights
26th Nov 20197:00 amRNSDirector/PDMR Shareholding
22nd Nov 20194:24 pmRNSDirector/PDMR Shareholding
22nd Nov 20199:22 amRNSAdditional Listing and Total Voting Rights
15th Nov 20197:00 amRNSAdditional Listing
4th Nov 20197:00 amRNSInvestor Report as at 30 September 2019
31st Oct 20197:00 amRNSScrip Share Reference Price
16th Oct 20193:54 pmRNSCommittee Changes
15th Oct 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
14th Oct 20197:00 amRNSNet Asset Value(s)
17th Sep 20197:00 amRNSDirector Composition Changes
30th Aug 20197:00 amRNSTotal Voting Rights
28th Aug 20192:01 pmRNSDirector/PDMR Shareholding
28th Aug 201910:58 amRNSDirector/PDMR Shareholding
27th Aug 201910:00 amRNSAdditional Listing and Total Voting Rights
22nd Aug 20197:00 amRNSAdditional Listing
6th Aug 20197:00 amRNSInvestor Report as at 28 June 2019
1st Aug 20197:00 amRNSScrip Share Reference Price
15th Jul 20197:00 amRNSNet Asset Value(s)
12th Jul 20192:42 pmRNSDividend Declaration & Scrip Dividend Alternative
1st Jul 20194:12 pmRNSChange of Administrator and Company Secretary Name
1st Jul 20194:05 pmRNSNew Directorship Notification
28th Jun 20197:00 amRNSTotal Voting Rights
4th Jun 20199:33 amRNSDirector/PDMR Shareholding
4th Jun 20199:33 amRNSDirector/PDMR Shareholding
4th Jun 20199:30 amRNSAdditional Listing and Total Voting Rights
24th May 201912:40 pmRNSAdditional Listing
23rd May 20197:00 amRNSHalf-yearly Report and Financial Statements 2019
20th May 20197:00 amRNSInvestment Commitment of c.£64 million
10th May 201912:12 pmRNSBespoke Supportive Tenancies
10th May 20198:47 amRNSScrip Share Reference Price
30th Apr 20197:00 amRNSInvestor Report as at 29 March 2019
25th Apr 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
16th Apr 20197:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.